Etiology of GVHD: Alloreactivity or Impaired Cellular Adaptation?

REFERENCES

• Baron F, Maris MB, Sandmaier BM, et al. (2005). Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol, 23(9), 1993–2003
   PubMed Web of Science ®Google Scholar
• Brown GR. (1999). Tumour necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. Gastroenterology, 116, 593–601
   PubMed Web of Science ®Google Scholar
• Choi IC, Fung PC, Leung AY, et al. (2001). Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipients. Haematologica, 86(9), 972–6
   PubMed Web of Science ®Google Scholar
• Cummins EP, Seeballuck F, Keely SJ, et al. (2008). The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology, 134, 156–65
   PubMed Web of Science ®Google Scholar
• Dietrich S, Okun JG, Schmidt K, et al. (2014). High pre-transplant serum nitrate levels predict risk of acute steroid-refractory graft-versus-host disease in the absence of statin therapy. Haematologica, 99(3), 541–7
   PubMed Web of Science ®Google Scholar
• Eriguchi Y, Uryu H, Nakamura K, et al. (2013). Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease. Biol Blood Marrow Transpl, 19, 1525–9
   PubMed Web of Science ®Google Scholar
• Frick JS, MacManus CF, Scully M, et al. (2009). Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol, 182, 4957–64
   PubMed Web of Science ®Google Scholar
• Garrett WS, Gordon JI, Glimcher LH. (2010). Homeostasis and Inflammation in the intestine. Cell 140, 859–70
   PubMed Web of Science ®Google Scholar
• Holmberg L, Kikuchi K, Gooley TA, et al. (2006). Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. Biol Blood Marrow Transpl, 12(2), 226–34
   PubMed Web of Science ®Google Scholar
• Hossain MS, Roback JD, Pollack BP, et al. (2007). Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood, 109(10), 4548–56
   PubMed Web of Science ®Google Scholar
• Jameson J, Ugarte K, Chen N, et al. (2002). A role for skin gammadelta T cells in wound repair. Science, 296(5568), 747–9
   PubMed Web of Science ®Google Scholar
• Jenq RR, Ubeda C, Taur Y, et al. (2012). Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med, 209, 903–11
   PubMed Web of Science ®Google Scholar
• Karhausen J, Furuta GT, Tomaszewski JE, et al. (2004). Epithelial hypoxiainducible factor-1 is protective in murine experimental colitis. J. Clin. Invest, 114, 1098–106
   PubMed Web of Science ®Google Scholar
• Li Q, Zhai Z, Xu X, et al. (2010). Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation. Leuk Res, 34(9), 1158–68
   PubMed Web of Science ®Google Scholar
• Manjili MH. (2014). The adaptation model of immunity. Immunotherapy, 6(1), 59–70
   PubMed Web of Science ®Google Scholar
• Marin GH, Porto A, Prates V, et al. (1999). Graft versus host disease in autologous stem cell transplantation. J Exp Clin Cancer Res, 18(2), 201–8
   PubMed Web of Science ®Google Scholar
• Matzinger P, Kamala T. (2011). Tissue-based class control: the other side of tolerance. Nat Rev Immunol, 11(3), 221–30
   PubMed Web of Science ®Google Scholar
• McNamee EN, Korns Johnson D, Homann D, et al. (2013). Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. Immunol Res, 55, 58–70
   PubMed Web of Science ®Google Scholar
• Mine KL, Shulzhenko N, Yambartsev A, et al. (2013). Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat Commun, 4, 1806 . doi: 10.1038/ncomms2693
   PubMed Web of Science ®Google Scholar
• Nash RA, Pepe MS, Storb R, et al. (1992). Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood, 80(7), 1838–45
   PubMed Web of Science ®Google Scholar
• Niederwieser D, Maris M, Shizuru JA, et al. (2003). Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood, 101(4), 1620–9
   PubMed Web of Science ®Google Scholar
• Nizet V, Johnson RS. (2009). Interdependence of hypoxic and innate immune responses. Nat Rev Immunol, 9, 609–17
   PubMed Web of Science ®Google Scholar
• Noth R, Lange-Grumfeld J, Stuber E, et al. (2011). Increased intestinal permeability and tight junction disruption by altered expression and localization of occludin in a murine graft versus host disease model. BMC Gastroenterol, 11, 109
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim JE, Lee JY, et al. (2004). Increased expression of IL-18 in cutaneous graft-versus-host disease. Immunol Lett, 95(1), 57–61
   PubMed Web of Science ®Google Scholar
• Pott J, Hornef M. (2012). Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep, 13, 684–98
   PubMed Web of Science ®Google Scholar
• Robinson A, Keely S, Karhausen J, et al. (2008). Mucosal protection by hypoxiainducible factor (HIF) prolyl hydroxylase inhibition. Gastroenterology, 134, 144–55
   Web of Science ®Google Scholar
• Rowlings PA, Przepiorka D, Klein JP, et al. (1997). IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol, 97(4), 855–64
   PubMed Web of Science ®Google Scholar
• Singhal S, Mehta J. (1999). Reimmunization after blood or marrow stel cell transplantation. Bone Marrow Transpl, 23(7), 637–46
   PubMed Web of Science ®Google Scholar
• Sirinoglu Demiriz I, Tekgunduz E, Tetik A, et al. (2013). Steroid refractory psoriasiform cutaneous graft versus host disease successfully treated by extracorporeal photopheresis: a case report. Transfus Apher Sci, 48(1), 109–11
   PubMed Web of Science ®Google Scholar
• Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C, Maloney DG, Storb R. (2004). Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood, 104(4), 961–8
   PubMed Web of Science ®Google Scholar
• Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem HP, Leisenring W, Shulman H. (1997). Stable mixed hematopoietic chimerism in dla-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood, 89(8), 3048–54
   PubMed Web of Science ®Google Scholar
• Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP. (2002). Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest, 110, 993–1002
   PubMed Web of Science ®Google Scholar
• Tsukamoto H, Chernogorova P, Ayata K, Gerlach UV, Rughani A, Ritchey JW, Ganesan J, Follo M, Zeiser R, Thompson LF, Idzko M. (2012). Deficiency of CD73/ecto-5′-nucleotidase in mice enhances acute graft-versus-host disease. Blood, 119(19), 4554–64
   PubMed Web of Science ®Google Scholar
• Wang L, Fan J, Chen S, Zhang Y, Curiel TJ, Zhang B. (2013). Graft-versus-host disease is enhanced by selective CD73 blockade in mice. PLoS One, 8(3), e58397
   Web of Science ®Google Scholar